Key ethics and policy issues in clinical psychedelic research

Clinical psychedelic research raises key ethics and policy issues that shape what kinds of studies can be approved, how risks are managed, and how benefits are communicated. Ethical questions include informed consent in settings that may involve altered states, participant vulnerability, and appropriate use of screening and follow up. Policy concerns focus on governance across regulators, clinicians, and institutions, including standards for study design, data transparency, and consistent oversight of safety monitoring. The article highlights why clear guidance matters for translating evidence into responsible clinical access.